Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-01 @ 12:56 PM
Study NCT ID:
NCT00842257
Status:
COMPLETED
Last Update Posted:
2017-05-16
First Post:
2009-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-10
First Submit QC Date:
None
Study First Post Date:
2009-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-10
Results First Submit QC Date:
None
Results First Post Date:
2017-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-10
Last Update Post Date:
2017-05-16
Last Update Post Date Type:
ACTUAL